|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07D 317/54 | |
| A61K 31/343 | |||
| A61P 13/04 | |||
| A61P 13/12 |
| (11) | Patento numeris | 3416955 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 17704274.4 |
| Europos patento paraiškos padavimo data | 2017-02-14 | |
| (97) | Europos patento paraiškos paskelbimo data | 2018-12-26 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2020-09-09 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/EP2017/053245 |
| Data | 2017-02-14 |
| (87) | Numeris | WO 2017/140658 |
| Data | 2017-08-24 |
| (30) | Numeris | Data | Šalis |
| 16305173 | 2016-02-15 | EP | |
| 16305698 | 2016-06-10 | EP |
| (72) |
LETAVERNIER, Emmanuel, FR
DAUDON, Michel, FR
|
| (73) |
Institut National de la Santé et de la Recherche Médicale (INSERM),
101, rue de Tolbiac, 75013 Paris,
FR
Assistance Publique - Hōpitaux de Paris, 3 avenue Victoria, 75004 Paris, FR Sorbonne Université, 21 Rue de l`Ecole de Médecine, 75006 Paris, FR |
| (54) | USE OF STIRIPENTOL AND THEIR DERIVATIVES FOR DECREASING URINARY OXALATE CONCENTRATION IN AN INDIVIDUAL |
| USE OF STIRIPENTOL AND THEIR DERIVATIVES FOR DECREASING URINARY OXALATE CONCENTRATION IN AN INDIVIDUAL |